No Data
No Data
TrivarX Completes Phase 2 MEB-001 Algorithm Sleep Study for Depressive Episodes
Medical health technology company TrivarX (ASX: TRI) has completed a Phase 2 sleep signal analysis for current major depressive episode (SAMDE) study utilising its proprietary artificial intelligence-backed algorithm MEB-001.
TrivarX Completes Phase 2 Sleep Signal Analysis for Current Major Depressive Episode Study; Shares Surge 11%
Mental health technology company TrivarX (ASX:TRI) completed phase 2 of its Sleep Signal Analysis for Current Major Depressive Episode study using its AI-backed algorithm, MEB-001, according to a
TRIVARX LTD Issues 12 Million Unquoted Options
TrivarX Ltd Aims for ASX Securities Quotation
TrivarX Recruits 362 Patients for Phase-Two MEB-001 Sleep Signal Analysis Study
TrivarX (ASX:TRI) has recruited 362 of the planned 400 patients for the second phase of a sleep signal analysis study that aims to validate the company's MEB-001 algorithm to assist in the screening a
TrivarX Receives Firm Commitments for AU$2.5 Million Share Issuance; Shares Jump 27%
TrivarX (ASX:TRI) secured firm commitments from new and existing institutional and sophisticated investors to raise AU$2.5 million, according to a Thursday filing with the Australian bourse. The menta
No Data
151430662 : I'll join the chat as I also have a small holding